Financial Assessment and Credit Risk Analysis of Veterinary Drug Industry in China 2016

  • ID: 3743235
  • Report
  • Region: China
  • 50 pages
  • ASKCI Consulting Co., Ltd
1 of 3
Introduction

In this report, the author analyzes the financial assessment and credit risk of the veterinary drug industry. It will provide you with a comprehensive understanding of this industry from the following aspects: development scale, operating benefit, related policies and industry analysis of major regions and provinces, as well as makescientific predictions on the future development of the veterinary drug industry.

The Aim of this report
- To provide readers with comprehensive & in- depth understanding of financial situation and credit risk on China’s veterinary drug industry;
- To understand the position of the veterinary drug industry in China;
- To Gain information on the major veterinary drug produced regions;
- To predict the future of China’s veterinary drug industry will be;
- To find out the region be worth for investment and the investment risks of veterinary drug industry in China;
- To reveal opportunities in the Chinese veterinary drug industry.

Benefits of the report
- Obtain latest financial information of veterinary drug industry in China, such as enterprise scale, total asset, sale revenueand total profit;
- Evaluate the status of the veterinary drug industry in China;
- Identify key trends and opportunities in China’s veterinary drug industry;
- Give the future prospects of China’s veterinary drug industry, and point out some investment risks it will face;
- Find out some regions where are best for investment in China’s veterinary drug industry.

Scope of Investigation
The report will investigate Chinese veterinary drug industry from the following aspects:
- Development analysis (Industry scale, Industry cost, etc.)
- Operation situation (Debt paying ability, operation ability, etc.)
- Major areas (major regions and top 5 provinces)
- Future forecast
- Commercial opportunity

Deliverables
Word- format report, with around 30- 50 pages;
Excel- format database of key regions and provinces of veterinary drug industry;

Delivery Time
3 weeks needed

Please note that this report takes 1-2 business days for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Overview and policy of veterinary drug industry in China
1.1 Overview of veterinary drug industry
1.1.1 Industry definition
1.1.2 Industry life cycle
1.1.3 Industry status in national economy
1.2 Policy of veterinary drug industry
1.2.1 Policy on veterinary drug industry
1.2.2 Policy on upstream and downstream industry

2 Development scale of China's veterinary drug industry
2.1 Industry scale analysis of veterinary drug industry in 2011-2015
2.1.1 Enterprise scale
2.1.2 Total asset
2.1.3 Sales revenue
2.1.4 Total profit
2.2 Industry cost analysis of veterinary drug industry in 2011-2015
2.2.1 Sale cost
2.2.2 Sales expense
2.2.3 Administration expense
2.2.4 Financial expense

3 Operating benefit analysis of veterinary drug industry
3.1 Debt paying ability analysis of veterinary drug industry in 2011-2015
3.1.1 Debt scale
3.1.2 Debt-to-assets ratio
3.2 Profitability analysis of veterinary drug industry in 2011-2015
3.2.1 Ratio of profits to cost
3.2.2 Gross profit to sales
3.2.3 Profit ratio of sales
3.2.4 Return on asset
3.3 Operation ability analysis veterinary drug industry in 2011-2015
3.3.1 Total assets turnover
3.3.2 Current asset turnover
3.3.3 Receivables turnover

4 Veterinary drug industry analysis in major regions
4.1 East China
4.1.1 Company number
4.1.2 Asset and liability
4.1.3 Sale revenue
4.1.4 Total profit
4.2 Central China
4.3 South China
4.3.1 Company number
4.3.2 Asset and liability
4.3.3 Sale revenue
4.3.4 Total profit

5 Veterinary drug industry analysis in Top 5 provinces
5.1 Province A
5.1.1 Enterprise scale
5.1.2 Total asset
5.1.3 Sales revenue
5.1.4 Total profit
5.1.5 Profitability analysis
5.1.6 Operation ability analysis
5.2 Province B
5.3 Province C

6 Future forecast of veterinary drug industry in China
6.1 Investment prospects
6.1.1 Development prospect analysis
6.1.2 Industry sale revenue forecast 2016 to 2020
6.1.3 Industry total profit forecast 2016 to 2020
6.2 Investment risk analysis
6.2.1 Industry policy risk
6.2.2 Raw material market risk
6.2.3 Market competition risk
6.2.4 Technology risk
6.3 Investment advices

List of Figures
Figure 1.1.2-1 Industry life cycle of veterinary drug industry in China
Figure 2.1.1-1 Enterprise scale distribution of China’s veterinary drug industry, 2015
Figure 2.1.2-1 Total asset of veterinary drug industry in China, 2011-2015
Figure 2.1.3-1 Sales revenue of veterinary drug industry in China, 2011-2015
Figure 2.1.4 Total profit of veterinary drug industry in China, 2011-2015

List of Tables
Table 1.2.1-1 Policy on veterinary drug industry in China, 2010-2016
Table 3.2.1-1 Ratio of profits to cost of veterinary drug industry in China, 2011-2015
Table 3.2.2-1 Gross profit to sales of veterinary drug industry in China, 2011-2015
Table 3.2.3-1 Profit ratio of sales of veterinary drug industry in China, 2011-2015
......
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll